Cited by 157Smoking Behavior and CessationInhalation and Respiratory Drug DeliveryNicotinic Acetylcholine Receptors Study

Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: a preliminary report

Open access
Ramôa, Carolina P, Hiler, Marzena M, Spindle, Tory R, Lopez, Alexa A, Karaoghlanian, Nareg, Lipato, Thokozeni, Breland, Alison B, Shihadeh, Alan +1 more·2016·Tobacco Control

Abstract

INTRODUCTION: Electronic cigarettes (ECIGs) aerosolise a liquid that usually contains propylene glycol and/or vegetable glycerine, flavourants and the dependence-producing drug, nicotine, in various concentrations. This laboratory study examined the relationship between liquid nicotine concentration and plasma nicotine concentration and puffing behaviour in experienced ECIG users. METHODS: Sixteen ECIG-experienced participants used a 3.3-Volt ECIG battery attached to a 1.5-Ohm dual-coil 'cartomiser' loaded with 1 mL of a flavoured propylene glycol/vegetable glycerine liquid to complete four sessions, at least 2 days apart, that differed by nicotine concentration (0, 8, 18 or 36 mg/mL). In each session, participants completed two 10-puff ECIG-use bouts (30 s puff interval) separated by 60 min. Venous blood was sampled to determine plasma nicotine concentration. Puff duration, volume and average flow rate were measured. RESULTS: Immediately after bout 1, mean plasma nicotine concentration was 5.5 ng/mL (SD=7.7) for 0 mg/mL liquid, with significantly (p<0.05) higher mean concentrations observed for the 8 (mean=17.8 ng/mL, SD=14.6), 18 (mean=25.9 ng/mL, SD=17.5) and 36 mg/mL (mean=30.2 ng/mL; SD=20.0) concentrations; a similar pattern was observed for bout 2. For bout 1, at 36 mg/mL, the mean post- minus pre-bout difference was 24.1 ng/mL (SD=18.3). Puff topography data were consistent with previous results and revealed few reliable differences across conditions. DISCUSSION: This study demonstrates a relationship between ECIG liquid nicotine concentration and user plasma nicotine concentration in experienced ECIG users. Nicotine delivery from some ECIGs may exceed that of a combustible cigarette. The rationale for this higher level of nicotine delivery is uncertain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/tobaccocontrol-2015-052447

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited by

Sorted by citations

Authors
Ramôa, C. P., Hiler, M. M., Spindle, T. R., Lopez, A. A., Karaoghlanian, N., Lipato, T., Breland, A. B., Shihadeh, A., & Eissenberg, T.
Affiliations
  • Virginia Commonwealth University (US)
  • American University of Beirut (LB)
Corresponding author
Eissenberg, Thomas
Venue
Tobacco Control
Publisher
BMJ
Published
2015-08-31
Volume
25
Issue
e1
Pages
e6-e9
ISSN
  • 0964-4563 (ISSN-L)
  • 1468-3318
OpenAlex
W2193842232
Cited by
157
References
0
Citations by year
2026: 4 · 2025: 1 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 16 · 2020: 19 · 2019: 25 · 2018: 21 · 2017: 26 · 2016: 19 · 2015: 1
FWCI
16.45
Type
journal article
Language
en
Open access
Locations
  • Tobacco Control (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Council for Science and Technology Policy
  • National Institutes of Health
  • National Institute on Drug Abuse (P50DA036105, F31DA040319)
  • Center for Tobacco Products (P50DA036105)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
electronic cigarettes, nicotine delivery, plasma nicotine concentration, puff topography, propylene glycol, combustible cigarettes, nicotine dependence
MeSH terms
Vaping, Smoking Prevention, Administration, Inhalation, Adult, Aerosols, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Nicotine, Smoking, Time Factors, Tobacco Use Disorder, Smoking Cessation, Nicotinic Agonists, Young Adult, Tobacco Products, Electronic Nicotine Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review